BioCentury
ARTICLE | Company News

In a rare M&A move, Amgen proposes to acquire partner Nuevolution

May 22, 2019 8:23 PM UTC

In what would be its first acquisition since 2015, Amgen offered on Wednesday to buy Copenhagen-based small molecule discovery company Nuevolution for about $167 million in cash.

Amgen Inc. (NASDAQ:AMGN) has proposed to pay SEK32.50 per share, a 169% premium over Nuevolution's close of SEK12.10 on Tuesday, for a total of SEK1.6 billion ($166.8 million)...

BCIQ Company Profiles

Amgen Inc.

Nuevolution AB